ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES
Review of current ideas about the role of acetylsalicylic acid (ASA) in the primary prevention of cardiovascular disease is presented. Data on reduction in malignant neoplasms incidence rate in long-term use of the drug, as well as prospects for further study of ASA in the primary prevention are con...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Stolichnaya Izdatelskaya Kompaniya
2015-09-01
|
Series: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
Subjects: | |
Online Access: | https://www.rpcardio.com/jour/article/view/110 |
id |
doaj-8a0e75dd3b244a19abb2455e12770380 |
---|---|
record_format |
Article |
spelling |
doaj-8a0e75dd3b244a19abb2455e127703802021-09-03T13:15:12ZengStolichnaya Izdatelskaya KompaniyaRacionalʹnaâ Farmakoterapiâ v Kardiologii1819-64462225-36532015-09-019443944310.20996/1819-6446-2013-9-4-439-443109ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUESE. N. Dankovtseva0Educational Scientific Medical Centre, Administrative Department of the President of the Russian Federation, City Clinical Hospital № 51, MoscowReview of current ideas about the role of acetylsalicylic acid (ASA) in the primary prevention of cardiovascular disease is presented. Data on reduction in malignant neoplasms incidence rate in long-term use of the drug, as well as prospects for further study of ASA in the primary prevention are considered.https://www.rpcardio.com/jour/article/view/110acetylsalicylic acidprimary preventioncancer |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
E. N. Dankovtseva |
spellingShingle |
E. N. Dankovtseva ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES Racionalʹnaâ Farmakoterapiâ v Kardiologii acetylsalicylic acid primary prevention cancer |
author_facet |
E. N. Dankovtseva |
author_sort |
E. N. Dankovtseva |
title |
ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES |
title_short |
ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES |
title_full |
ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES |
title_fullStr |
ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES |
title_full_unstemmed |
ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES |
title_sort |
acetylsalicylic acid: controversial and outstanding issues |
publisher |
Stolichnaya Izdatelskaya Kompaniya |
series |
Racionalʹnaâ Farmakoterapiâ v Kardiologii |
issn |
1819-6446 2225-3653 |
publishDate |
2015-09-01 |
description |
Review of current ideas about the role of acetylsalicylic acid (ASA) in the primary prevention of cardiovascular disease is presented. Data on reduction in malignant neoplasms incidence rate in long-term use of the drug, as well as prospects for further study of ASA in the primary prevention are considered. |
topic |
acetylsalicylic acid primary prevention cancer |
url |
https://www.rpcardio.com/jour/article/view/110 |
work_keys_str_mv |
AT endankovtseva acetylsalicylicacidcontroversialandoutstandingissues |
_version_ |
1717817155219619840 |